Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Altered DHEA metabolism in hair follicles may be linked to hair loss in balding men.

Certain compounds can protect hair cells from aging and promote growth.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Alopecia areata affects hair follicle structure, even in non-balding areas.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

Treat the front and middle scalp before the vertex in hair transplants, aim for good density, use non-surgical options for young people, and customize treatment for natural results.

The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.

Bald men are often viewed more negatively and as older than they really are.

Leukokoria can signal Coats disease or other retinal issues, requiring early detection to prevent severe outcomes.

Caffeine and DMG increase calcium influx in hair follicle cells without being toxic.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Reducing PEDF may help treat hair loss.

Two siblings had a rare hair condition with banded hair, which doesn't need treatment.

miR-122 causes hair loss by killing hair cells.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Different hair loss patterns may be linked to varying male hormone levels.

No genetic link between prostaglandins and hair loss found.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.